Eli Lilly

President Trump's tariffs are poised to impact the pharmaceutical industry despite longstanding norms that have insulated the industry — and consumers — from tr...

Hims & Hers investors are clearly antsy about where the company’s weight-loss business is going and Tuesday’s announcement was supposed to help clear that up —...

Shares of Hims & Hers Health (HIMS) rallied on Tuesday after the telehealth company said it would begin selling branded versions of Eli Lilly’s (LLY) popular we...

Hims & Hers Health Inc HIMS shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli Lilly And Co’s LLY Zepbound through its T...

Hims & Hers is unable to sell copies of GLP-1 agonists after the FDA declared the shortage of those drugs is over. Hims & Hersshares soared Tuesday afternoon a...

Shares of Hims & Hers Health (NYSE:HIMS) traded higher on Tuesday after the telehealth company announced the addition of branded versions of Eli Lilly’s (NYSE:L...

U.S. pharmaceutical giant Eli Lilly (LLY) is suing two pharmacies for illegally making knock-off copies of its weight loss and diabetes drugs. Specifically, El...

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound. The pharm...

Eli Lilly (LLY) is targeting additional drug compounders and telehealth companies that make copycat versions of its weight loss drug, with plans to file two law...

After revolutionizing the weight-loss drug market, Novo Nordisk (NVO) and Eli Lilly (LLY) are setting their sights on heart health. Both pharma giants unveiled...